Semaglutide once weekly in people with type 2 diabetes: Real‐world analysis of the Canadian LMC diabetes registry (SPARE study)

Tekijä Brown, Ruth E, Bech, Peter G, Aronson, Ronnie
Julkaisussa Diabetes Obes Metab (2020)

Economic evaluation of SQ-standardized grass allergy immunotherapy tablet (Grazax(®)) in children

Tekijä Ronaldson, Sarah, Taylor, Matthew, Bech, Peter G, Shenton, Ruth, Bufe, Albrecht
Julkaistu 2014

Cost Effectiveness of Once-Weekly Semaglutide Versus Once-Weekly Dulaglutide in the Treatment of Type 2 Diabetes in Canada

Tekijä Johansen, Pierre, Håkan-Bloch, Jonas, Liu, Aiden R., Bech, Peter G., Persson, Sofie, Leiter, Lawrence A.
Julkaisussa Pharmacoecon Open (2019)